Navigation Links
Rijuven Debuts CardioSleeve, an FDA Cleared Stethoscope Attachment with 3-Lead ECG and Digital Auscultation that Wirelessly Connects to Mobile Devices

Wexford, PA (PRWEB) July 10, 2013

Startup Rijuven Corp. ( is announcing the debut of CardioSleeve v1.0, the first FDA cleared stethoscope accessory device for clinicians to acquire 3-Lead ECG and Digital Auscultation at any point of care. CardioSleeve enhances the traditional stethoscope by recording, displaying and analyzing electrical and acoustical footprints of the heart in real time via any wirelessly connected portable device. Rijuven received FDA clearance for CardioSleeve v1.0 on June 25, 2013. The device, slated as the first accessory device that enhances the diagnostic capability of the traditional stethoscope, is expected to be available by Q4, 2013.

During the physical examination of a patient, heart sound auscultation is subjective to the hearing, experience and training limitations of the clinician, which can lead to missed diagnosis and additional costly tests. The traditional ECG requires expensive cart machines with wired electrodes, which restricts access.

Rijuven combines and improves on these cardio-diagnostic processes by allowing a clinician to attach the CardioSleeve to an existing stethoscope to acquire the digital acoustic and electric footprints of the heart and transmits them to a mobile device for real time analysis at any point of care.

“With over 40 million stethoscopes, used worldwide, Rijuven’s innovative add-on CardioSleeve digital technology will help revolutionize assessment and diagnosis of patients far more effectively, efficiently, and empathetically at any point of care, in almost any clinical scenario...” said Raj Kapoor, MD, FCCP, President, Rijuven Corp.

CardioSleeve’s patent pending device and mobile app platform attaches to any stethoscope to offer the following features:

  •     Digital Auscultation with ECG
  •     Murmur Detection and Analysis
  •     3- Lead ECG
  •     Digital Caliper
  •     Cardiac Index Est.
  •     Wireless connectivity to smartphone, tablet, laptop and PC
  •     Cloud EMR Archival

The merging of innovative sensor technology and mobile app allow a clinician to acquire, analyze and share digital heart sound recordings and 3-Lead ECG more timely and cost effectively, while maintaining control of the diagnostic decision making process.

Rijuven is planning the release of CardioSleeve v 1.0 to clinicians in Q4 2013, with additional device and app diagnostics to follow to create a pipeline of compelling products across multiple specialties. Rijuven also plans to introduce consumer wellness devices utilizing its underlying patent pending technology.

“Nothing better epitomizes Rijuven’s DNA and unique innovative spirit, than the revolutionary technology behind the CardioSleeve. It allows a physician to instantly acquire and analyze acoustic and electrical footprints of the patient’s heart on any mobile device at any point of care. This unquestionably enhances quality patient care, saves lives and reduces health care cost.” said Kapoor.

About the Company: Rijuven Corp. was founded by Raj Kapoor, MD, FCCP and technologist Evens Augustin to commercialize medical devices that have a world impact. The team of clinicians, technologists, designers and innovation strategists have come together to transform medical device markets and revolutionize care delivery through the use of select innovations that increase outcomes, drive down costs and expand care access.

For more information, please visit: or email: media (at) rijuven (dot) com.

Read the full story at

Source: PRWeb
Copyright©2012 Vocus, Inc.
All rights reserved

Related medicine news :

1. Brightree Debuts on List of Top 100 Healthcare Technology Companies
2. Nexus Connected Healthcare Debuts on the 2013 Healthcare Informatics Top 100 List
3. Just Home Medical Debuts Updated Selection of Overbed Tables
4. Debuts Their Brand New Beauty Kits
5. Modernfold Debuts New Colors and Patterns for Space Division Products
6. Catalyst Exhibits Debuts 360 Degree Virtual Tour of St. Jude Medical Trade Show Booth
7. Allayo Debuts Virtual Health Assistant At HealthBeat 2013
8. Sojourn Debuts Deluxe Weekend Bike Tours in Vermont for Summer 2013
9. Amirsys Debuts Amirsys Reference Centers at Medical Library Association Meeting
10. Quin Woodward Pu Debuts 2nd Memoir, DIGFAST
11. Zayak Sea Sled Debuts the Resort Rental Model
Post Your Comments:
(Date:11/27/2015)... (PRWEB) , ... November 27, 2015 , ... ... affecting the health care in America. As people age, more care is needed, ... costs are rising, and medical professionals are being overworked. The forgotten part of ...
(Date:11/27/2015)... CA (PRWEB) , ... November 27, 2015 , ... Lizzie’s ... , The company is offering customers 10% off of their purchase of lice treatment ... treatment at full price. According to a company spokesperson. “Finding lice is a sure ...
(Date:11/27/2015)... ... November 27, 2015 , ... Consistent with the Radiology ... Building Better Radiology Marketing Programs meeting will showcase some of the best ... at Caesars Palace in Las Vegas with a pre-conference session on a collaborative ...
(Date:11/27/2015)... ... November 27, 2015 , ... Keeping in mind ... mental health and wellness consultation, has collaborated with a leading web-based marketplace for ... gap experienced by parents and bring advice from parenting experts within their reach. ...
(Date:11/27/2015)... ... , ... Avid collector, Andrew Hawley from Vintage Rock Posters, announces his search ... one of Joplin's most famous and beautiful concert posters. The concert was held on ... Arbor. The According to Hawley, "It is hard to believe that Joplin's stardom was ...
Breaking Medicine News(10 mins):
(Date:11/25/2015)... , Nov. 25, 2015 ... the addition of the "Global Brain ... their offering. --> ) ... "Global Brain Monitoring Devices Market 2015-2019" ... Research and Markets ( ) has ...
(Date:11/25/2015)... THOUSAND OAKS, Calif. , Nov. 25, 2015 /PRNewswire/ ... of a Biologics License Application (BLA) with ... Administration (FDA) for ABP 501, a biosimilar candidate to ... the first adalimumab biosimilar application submitted to the FDA ... biosimilar pathway. Sean E. Harper , M.D., ...
(Date:11/25/2015)... WOODBURY, N.Y. , Nov. 25, 2015  Linden ... access and optimizing treatment outcomes for patients suffering from ... its request for a Temporary Restraining Order (TRO) enjoining ... between the two companies. --> ... aggressively pursuing all of its legal options. ...
Breaking Medicine Technology: